ACM
COGT icon

Aster Capital Management’s Cogent Biosciences COGT Stock Holding History

Aster Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.45K Buy
+409
New +$15.1K ﹤0.01% 747
2025
Q2 		– Sell
-2,061
Closed -$15.5K – 1124
2025
Q1 		$15.5K Buy
2,061
+1,466
+246% +$11.5K ﹤0.01% 1013
2024
Q4 		$4.64K Buy
595
+482
+427% +$4.8K ﹤0.01% 870
2024
Q3 		$1.22K Buy
+113
New +$1.1K ﹤0.01% 1005

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Aster Capital Management's COGT Position: Q1 2026 in Review

Aster Capital Management opened a new position in Cogent Biosciences (COGT) in Q1 2026: 409 shares worth $2.45K. The stake represents ﹤0.01% of the portfolio and ranks #747 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in COGT as recently as Q1 2025.

Aster Capital Management first reported a position in COGT in Q3 2024 and has held it in 4 quarters since. The position peaked at $15.5K in Q1 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Aster Capital Management held 409 shares of Cogent Biosciences worth $2.45K as of Q1 2026.
  • Cogent Biosciences was a new Aster Capital Management position in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #747 holding.
  • Aster Capital Management first reported a position in Cogent Biosciences in Q3 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Cogent Biosciences position peaked at $15.5K in Q1 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.